Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Health Sciences profile

Dr Claire Henry

PositionResearch Fellow
DepartmentDepartment of Obstetrics, Gynaecology and Women's Health (Wellington)
QualificationsBSc(Hons I) PhD
Research summaryGynaecological cancers

Research

Claire's research background is in molecular cell biology and genetics of gynaecological cancers, in particular ovarian and endometrial. She is interested in:
  • Mutations in endometrial cancer
  • Obesity related interventions for endometrial cancer
  • Early detection test for ovarian cancer
  • HPV screening programs

Publications

Paterson, E., Blenkiron, C., Danielson, K., & Henry, C. (2022). Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context. Translational Oncology, 23, 101478. doi: 10.1016/j.tranon.2022.101478

Kanagasabai, P. S., Filoche, S., Grainger, R., Henry, C., & Hay-Smith, J. (2022). Interventions to improve access to care for abnormal uterine bleeding: A systematic scoping review. International Journal of Gynecology & Obstetrics. Advance online publication. doi: 10.1002/ijgo.14224

Clarricoats, G., Ormandy, J., Henry, C., Meikle, A., & Filoche, S. (2021). COVID-19 vaccination in pregnancy: Time to act, time to advocate. Australian & New Zealand Journal of Obstetrics & Gynaecology, 61(6), E30. doi: 10.1111/ajo.13461

Henry, C. E., Phan, K., Orsman, E. J. O., Kenwright, D., Thunders, M. C., & Filoche, S. K. (2021). Molecular profiling of endometrial cancer: An exploratory study in Aotearoa, New Zealand. Cancers, 13(22), 5641. doi: 10.3390/cancers13225641

Dore, M., Filoche, S., Danielson, K., & Henry, C. (2021). Characterisation of levonorgestrel-resistant endometrial cancer cells. Cancer Management & Research, 13, 7871-7884. doi: 10.2147/CMAR.S327381

Dore, M., Filoche, S., Danielson, K., & Henry, C. (2021). Characterisation of levonorgestrel-resistant endometrial cancer cells. Cancer Management & Research, 13, 7871-7884. doi: 10.2147/CMAR.S327381

Journal - Research Article

Henry, C. E., Phan, K., Orsman, E. J. O., Kenwright, D., Thunders, M. C., & Filoche, S. K. (2021). Molecular profiling of endometrial cancer: An exploratory study in Aotearoa, New Zealand. Cancers, 13(22), 5641. doi: 10.3390/cancers13225641

Journal - Research Article

Henry, C., Ekeroma, A., Dowell, A., & Filoche, S. (2021). 'The horror stories put me off!': Exploring women's acceptability of the Levonorgestrel IntraUterine System (LNG-IUS) for endometrial protection. Journal of Primary Health Care, 13(1), 55-62. doi: 10.1071/HC20105

Journal - Research Article

Henry, C., Ekeroma, A., & Filoche, S. (2020). Barriers to seeking consultation for abnormal uterine bleeding: Systematic review of qualitative research. BMC Women's Health, 20, 123. doi: 10.1186/s12905-020-00986-8

Journal - Research Article

Henry, C., Jefferies, R., Ekeroma, A., & Filoche, S. (2020). Beyond the numbers-understanding women's experiences of accessing care for abnormal uterine bleeding (AUB): A qualitative study. BMJ Open, 10, e041853. doi: 10.1136/bmjopen-2020-041853

Journal - Research Article

Lu, M., Henry, C. E., Lai, H., Khine, Y. Y., Ford, C. E., & Stenzel, M. H. (2019). A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles. Biomaterials Science, 7, 1652-1660. doi: 10.1039/c8bm01326h

Journal - Research Article

Cortesi, M., Llamosas, E., Henry, C. E., Kumaran, R.-Y. A., Ng, B., Youkhana, J., & Ford, C. E. (2018). I-AbACUS: A reliable software tool for the semi-automatic analysis of invasion and migration transwell assays. Scientific Reports, 8, 3814. doi: 10.1038/s41598-018-22091-5

Journal - Research Article

Henry, C. E., Llamosas, E., Daniels, B., Coopes, A., Tang, K., & Ford, C. E. (2018). ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. Gynecologic Oncology, 148(3), 576-584. doi: 10.1016/j.ygyno.2018.01.025

Journal - Research Article

Henry, C. E., Emmanuel, C., Lambie, N., Loo, C., Kan, B., Kennedy, C. J., … Ford, C. E. (2017). Distinct patterns of stromal and tumor expression of ROR1 and ROR2 in histological subtypes of epithelial ovarian cancer. Translational Oncology, 10(3), 346-356. doi: 10.1016/j.tranon.2017.01.014

Journal - Research Article

Henry, C., Hacker, N., & Ford, C. (2017). Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis. Oncotarget, 8(68), 112727-112738. doi: 10.18632/oncotarget.22559

Journal - Research Article

Ma, S. S. Q., Henry, C. E., Llamosas, E., Higgins, R., Daniels, B., Hesson, L. B., … Ford, C. E. (2017). Validation of specificity of antibodies for immunohistochemistry: The case of ROR2. Virchows Archiv, 470(1), 99-108. doi: 10.1007/s00428-016-2019-5

Journal - Research Article

Henry, C. E., Llamosas, E., Djordjevic, A., Hacker, N. F., & Ford, C. E. (2016). Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer. Oncogenesis, 5, e226. doi: 10.1038/oncsis.2016.32

Journal - Research Article

Henry, C., Llamosas, E., Knipprath-Meszaros, A., Schoetzau, A., Obermann, E., Fuenfschilling, M., … Ford, C. (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Oncotarget, 6, 40310-40326. doi: 10.18632/oncotarget.5643

Journal - Research Article

Henry, C., Quadir, A., Hawkins, N. J., Jary, E., Llamosas, E., Kumar, D., … Ford, C. E. (2015). Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling. Journal of Cancer Research & Clinical Oncology, 141, 243-254. doi: 10.1007/s00432-014-1824-y

Journal - Research Article

Ford, C. E., Punnia-Moorthy, G., Henry, C. E., Llamosas, E., Nixdorf, S., Olivier, J., … Heinzelmann-Schwarz, V. (2014). The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer. Gynecologic Oncology, 134(2), 338-345. doi: 10.1016/j.ygyno.2014.06.004

Journal - Research Article

Kanagasabai, P. S., Filoche, S., Grainger, R., Henry, C., & Hay-Smith, J. (2022). Interventions to improve access to care for abnormal uterine bleeding: A systematic scoping review. International Journal of Gynecology & Obstetrics. Advance online publication. doi: 10.1002/ijgo.14224

Journal - Research Other

Paterson, E., Blenkiron, C., Danielson, K., & Henry, C. (2022). Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context. Translational Oncology, 23, 101478. doi: 10.1016/j.tranon.2022.101478

Journal - Research Other

Clarricoats, G., Ormandy, J., Henry, C., Meikle, A., & Filoche, S. (2021). COVID-19 vaccination in pregnancy: Time to act, time to advocate. Australian & New Zealand Journal of Obstetrics & Gynaecology, 61(6), E30. doi: 10.1111/ajo.13461

Journal - Research Other

Dore, M., Filoche, S., Danielson, K., & Henry, C. (2021). Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response? Gynecologic Oncology Reports, 36, 100732. doi: 10.1016/j.gore.2021.100732

Journal - Research Other

Henry, C., Filoche, S., Thunders, M., Kenwright, D., & Ekeroma, A. (2019). Reflection on the current status of endometrial cancer in New Zealand. Australian & New Zealand Journal of Obstetrics & Gynaecology, 59, 874-876. doi: 10.1111/ajo.13057

Journal - Research Other

Ford, C. E., Henry, C., Llamosas, E., Djordjevic, A., & Hacker, N. (2016). Wnt signalling in gynaecological cancers: A future target for personalised medicine? Gynecologic Oncology, 140, 345-351. doi: 10.1016/j.ygyno.2015.09.085

Journal - Research Other

More publications...